Management of Volume Overload in Dialysis Patients with CHF

Primary Strategy: Optimize Dialysis Prescription

• The American Journal of Kidney Diseases recommends reassessing and adjusting the PD prescription monthly to maximize peritoneal ultrafiltration, focusing on drain volume, residual kidney function, and dietary salt/water intake 1
• The American Journal of Kidney Diseases suggests eliminating net peritoneal fluid absorption that commonly occurs during long-duration dwells by modifying the prescription 1
• The American Journal of Kidney Diseases advises reevaluating target dry weight through monthly clinical examination, particularly during initial PD therapy establishment 1
• The American Journal of Kidney Diseases recommends measuring total sodium and water removal by assessing daily urinary volume/sodium content and calculating the difference between dialysate effluent and infused solution over 24 hours 1

Adjunctive Diuretic Therapy (If Residual Renal Function Present)

• The American College of Cardiology recommends administering higher doses of intravenous loop diuretics (furosemide equivalent) than in non-dialysis patients, as drug delivery to tubules is reduced in advanced CKD 2
• The American College of Cardiology states that loop diuretics remain effective until eGFR falls below 20-30 mL/min, but efficacy diminishes significantly in dialysis-dependent patients 2
• The American Journal of Kidney Diseases suggests considering diuretics to preserve remaining kidney function, but recognizes their limited role once anuric 1

Dietary and Fluid Management

• The American Journal of Kidney Diseases recommends restricting dietary sodium to 2-3 grams daily as the cornerstone of volume management in dialysis patients 1
• The American College of Cardiology advises implementing fluid restriction to 2 liters daily if persistent volume overload despite optimized dialysis 2
• The American Journal of Kidney Diseases recommends monitoring interdialytic weight gain closely, as excessive gains indicate inadequate sodium/fluid restriction 1

Monitoring Requirements

• The American Journal of Kidney Diseases recommends assessing volume status monthly at minimum through clinical examination, including evaluation of blood pressure, edema, jugular venous pressure, and lung examination 1
• The American Heart Association recommends monitoring serum electrolytes, BUN, and creatinine during any diuretic therapy adjustments 3
• The American College of Cardiology suggests tracking daily weights to guide ultrafiltration targets and assess treatment response 3

Guideline-Directed Medical Therapy Considerations

• The American Heart Association recommends continuing ACE inhibitors/ARBs and beta-blockers unless hemodynamically unstable, as volume optimization improves tolerance of these medications 3
• The American College of Cardiology advises initiating or uptitrating beta-blockers at low doses after achieving volume optimization and discontinuing intravenous agents 3

Hospital Discharge Planning

• The American Heart Association recommends ensuring stable dialysis prescription that maintains euvolemia before discharge 3
• The American College of Cardiology suggests scheduling follow-up within 7-14 days with telephone contact within 3 days to assess volume status and prevent readmission 3
• The American Heart Association advises reinforcing sodium/fluid restriction education and providing emergency plans for rapid weight gain 3

Isolated Ultrafiltration for Refractory Volume Overload

Therapeutic Option

Physiologic Rationale

Clinical Evidence